Skip to main content
S 2901 116th Congress Senate

Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2019

Official title: A bill to establish within the Office of the Secretary of Health and Human Services a special task force on ensuring Medicare beneficiary access to innovative diabetes technologies and services.

Introduced: November 19, 2019 Introduced by: Collins, Susan M. Republican · Maine See on congress.gov
Health Administrative law and regulatory proceduresAdvanced technology and technological innovationsAdvisory bodiesCongressional oversight
More subjectsShow fewer subjects
Department of Health and Human ServicesDigestive and metabolic diseasesDrug safety, medical device, and laboratory regulationHealth care coverage and accessHealth technology, devices, suppliesMedical researchMedicare
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 19, 2019
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S6673)
Nov 19, 2019
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action November 19, 2019

Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S6673)

 Plain-English summary Congressional Research Service

Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2019

This bill establishes the Task Force on Innovative Diabetes Technologies and Services to address the accessibility of innovative diabetes technologies and services to Medicare beneficiaries. The bill defines innovative diabetes technologies and services as medical technologies and services for diabetes treatment that are not covered under Medicare.

Among other activities, the task force must (1) recommend ways to improve access to innovative diabetes technologies and services through new or alternative payment models and existing policies, and (2) propose changes to foster collaboration between the Food and Drug Administration and the Centers for Medicare & Medicaid Services to streamline approval and coverage.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1
D
Shaheen, Jeanne
New Hampshire · Nov 19, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2901: Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-S-2901/
MLA
"S. 2901: Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-2901/.
Bluebook (legal)
S. 2901, 116th Cong. (2026), https://openamerica.io/bill/116-S-2901/.
Markdown link
[S. 2901: Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2019](https://openamerica.io/bill/116-S-2901/)
Report a problem